Taiwan FDA registration e8ccac28ffbc18b1e7ed02461ae44113
"Covidien" thin and light implantable drug delivery system
TW: “柯惠”輕薄型植入式釋藥系統
Taiwan·Risk Class 2·COVIDIEN LLC;; COVID·Registered Jul 27, 2012 – Jul 01, 2016CancelledRegistration details
- Analysis ID
- e8ccac28ffbc18b1e7ed02461ae44113
- Customs Code
- DHA00602372202
Company information
- Manufacturer
- COVIDIEN LLC;; COVID
- Manufacturer Country
- United States
- Authorized Representative
- Taiwan Covidien Corporation Limited
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- J General hospital and personal use equipment
- Product Type (Level 2)
- J.5965 Subcutaneous implantable intravascular injection port and guide
- Import Information
- import
Dates and status
- Registration Date
- Jul 27, 2012
- Expiry Date
- Jul 01, 2016
- Cancellation Date
- Jun 20, 2016
Cancellation information
- Status
- Logged out
- Reason
- 自請註銷
About this record
Access comprehensive regulatory information for "Covidien" thin and light implantable drug delivery system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e8ccac28ffbc18b1e7ed02461ae44113 and manufactured by COVIDIEN LLC;; COVID. The authorized representative in Taiwan is Taiwan Covidien Corporation Limited.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices